Leukocyte nucleic acids

Leukocyte nucleic acids refer to DNA and RNA molecules present in white blood cells (leukocytes), which are essential components of the immune system. DNA in leukocytes stores genetic information as a double-stranded helix, serving as the blueprint for cellular functions including immune responses, while RNA—primarily messenger RNA (mRNA), ribosomal RNA (rRNA), and transfer RNA (tRNA)—facilitates transcription from DNA, protein synthesis at ribosomes, and gene regulation through processes like splicing and RNA interference[1][2][3][4][7]. These nucleic acids enable leukocytes to perform critical roles such as pathogen defense, antibody production, and cytokine signaling, with RNA also contributing to cellular differentiation and response to environmental changes[2][6]. Dysregulation of leukocyte nucleic acids, such as mutations in DNA or aberrant RNA expression, is implicated in diseases like cancer (e.g., leukemias), viral infections, and autoimmune inflammation, where altered gene expression drives uncontrolled proliferation or immune dysfunction[2][6]. However, leukocyte nucleic acids are not recognized as a specific therapeutic target like receptors or enzymes; instead, they are broadly studied in gene therapy, RNA-based vaccines, and diagnostics, with no direct small-molecule drugs targeting them as a class[1][4][7]. Challenges in targeting nucleic acids include off-target effects and delivery issues in therapeutics like antisense oligonucleotides or siRNAs[2].

Other names

Leukocyte DNALeukocyte RNADNA in leukocytesRNA in leukocytes